Skip to content
It's time to build
Nav Opener
  • Portfolio
  • Team
  • Focus Areas
    • American Dynamism
    • Bio + Health
    • Cultural Leadership Fund
    • Consumer
    • Crypto
    • Enterprise
    • Fintech
    • Games
    • Growth
    • Talent x Opportunity
  • Content
    Topics
    • Fintech
    • Gaming & Social
    • Security & Privacy
    • Marketplaces
    • Enterprise & SaaS
    • Bio + Health
    • Creator Economy
    • Cryptocurrencies & Blockchains
    Type
    • Articles
    • Video
    • Podcasts
    • Newsletters
  • About
  • Jobs
Close

Julie Yoo

Julie Yoo Download Photo

Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system. 

Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access. Julie led product management, engineering, and sales and marketing for the company, and helped scale the business to reach 20M patients and over 225,000 healthcare providers across the U.S.

Julie was previously VP of Product at Generation Health, and was with the company from its inception through acquisition by CVS Health. Julie was also a Product Manager at Knome, the world's first whole genome sequencing service for private individuals. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle. 

Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health.

Julie serves on a number of portfolio company boards, including AKASA, Bayesian Health, Firefly Health, Patina, Ribbon Health, Season Health, Sprinter Health, Tomorrow Health, Turquoise Health and Zus Health.

Latest Posts

Payvidors, Unbundled: Opportunities in Healthcare Fintech

by Marc Andrusko, David Haber, Daisy Wolf, and Julie Yoo
  • bio + health
  • fintech

Investing in Turquoise Health

by Julie Yoo
  • bio + health

Risk-based Contracting for Value-based Care, a Founder’s Playbook

by Justin Larkin and Julie Yoo
  • bio + health
  • Digital Health Builders
  • go to market
  • healthcare
  • videos

Investing in Season Health

by Julie Yoo
  • bio + health
  • food x tech

From @julesyoo

Julie Yoo@julesyoo

Why don’t we fight cancer like we fight viruses? My partner @JorgeCondeBio’s thoughts on partnering with Alexis Borisy once again as he goes back into the ring with IDRx. https://t.co/VqrFZeSgx1

Jorge Conde@JorgeCondeBio

We’re in a new golden age for small molecules. Novel classes of small molecules bring new capabilities. PROTACs target proteins for degradation + disposal. Now @VicinitasTx is developing DUBTACs—the opposite of PROTACs—to stabilize proteins. https://t.co/9aWTr3mDYi

Julie Yoo@julesyoo

1/ Digital Health Builders: we're back with GTM Playbook #3. This one focuses on a particularly juicy GTM motion thru which a company becomes the indispensable bridge between two markets - the 2-sided network play. https://t.co/LFq9oqmOd4 https://t.co/mDRpL0AO7Y

Software is eating the world
© 2022 Andreessen Horowitz
Software is eating the world
    • Twitter
    • Simplecast
  • Contact
  • Jobs
  • Briefings
  • Terms of Use & Privacy
  • Disclosures
  • Conduct
  • Who We Are